Skip to main content
SpringerLink
Log in

Risk of cancer with ranitidine or nizatidine?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Iwagami M, et al. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018. Drug Safety : 27 Nov 2020. Available from: URL: https://doi.org/10.1007/s40264-020-01024-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of cancer with ranitidine or nizatidine?. Reactions Weekly 1834, 11 (2020). https://doi.org/10.1007/s40278-020-87203-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-87203-9

Search

Navigation